The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback